Maladie oligométastatique dans le cancer bronchique non à petites cellules

Blanchon, 2002, Épidémiologie du cancer bronchique primitif pris en charge dans les centres hospitaliers généraux français, Rev Mal Respir, 19, 727 Walters, 2013, Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a populationbased study, 2004–2007, Thorax, 68, 551, 10.1136/thoraxjnl-2012-202297 Azzoli, 2009, American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer, J Clin Oncol, 27, 6251, 10.1200/JCO.2009.23.5622 Paz-Ares, 2012, Lancet Oncol, 13, 247, 10.1016/S1470-2045(12)70063-3 Paz-Ares, 2013, PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer, J Clin Oncol, 31, 2895, 10.1200/JCO.2012.47.1102 Ciuleanu, 2009, Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-smallcell lung cancer: a randomised, double-blind, phase 3 study, Lancet, 374, 1432, 10.1016/S0140-6736(09)61497-5 Coudert, 2012, Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy, Ann Oncol, 23, 388, 10.1093/annonc/mdr125 Pérol, 2012, Randomized, Phase III Study of Gemcitabine or Erlotinib Maintenance Therapy Versus Observation, With Predefined Second-Line Treatment. After Cisplatin-Gemcitabine Induction Chemotherapy in Advanced Non-Small-Cell Lung Cancer, J Clin Oncol, 30, 3516, 10.1200/JCO.2011.39.9782 Zukin, 2013, Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2, J Clin Oncol, 31, 2849, 10.1200/JCO.2012.48.1911 Quoix, 2011, Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial, Lancet, 378, 1079, 10.1016/S0140-6736(11)60780-0 Sandler, 2006, Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer, N Engl J Med, 355, 2542, 10.1056/NEJMoa061884 Shepherd, 2000, Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy, J Clin Oncol, 18, 2095, 10.1200/JCO.2000.18.10.2095 Hanna, 2004, Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy, J Clin Oncol, 22, 1589, 10.1200/JCO.2004.08.163 Shepherd, 2005, Erlotinib in previously treated non-smallcell lung cancer, N Engl J Med, 353, 123, 10.1056/NEJMoa050753 Schiller, 2002, Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer, N Engl J Med, 346, 92, 10.1056/NEJMoa011954 Rosell, 2012, Erlotinib versus standard chemotherapy as firstline treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial, Lancet Oncol, 13, 239, 10.1016/S1470-2045(11)70393-X Mok, 2009, Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma, N Engl J Med, 361, 947, 10.1056/NEJMoa0810699 Shaw, 2013, Crizotinib versus chemotherapy in advanced ALK-positive lung cancer, N Engl J Med, 368, 2385, 10.1056/NEJMoa1214886 Ballantyne, 2013, Dabrafenib: first global approval, Drugs, 73, 1367, 10.1007/s40265-013-0095-2 Weichselbaum, 2011, Oligometastases revisited, Nat Rev Clin Oncol, 8, 378, 10.1038/nrclinonc.2011.44 Hellman, 1995, Oligometastases, J Clin Oncol, 13, 8, 10.1200/JCO.1995.13.1.8 Albain, 1991, Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience, J Clin Oncol, 9, 1618, 10.1200/JCO.1991.9.9.1618 Jabbour, 2011, A novel paradigm in the treatment of oligometastatic non-small cell lung cancer, J Thorac Dis, 3, 4 Ambrogi, 2001, Prolonged survival after extracranial metastasectomy from synchronous resectable lung cancer, Ann Surg Oncol, 8, 663, 10.1007/s10434-001-0663-7 Mordant, 2012, Which metastasis management allows longterm survival of synchronous solitary M1b non-small cell lung cancer?, Eur J Cardiothorac Surg, 41, 617, 10.1093/ejcts/ezr042 De Pas, 2007, Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era, Ann Thorac Surg, 83, 231, 10.1016/j.athoracsur.2006.08.017 Ashworth, 2013, Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature, Lung Cancer, 82, 197, 10.1016/j.lungcan.2013.07.026 Peters, 2012, Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 23, 56, 10.1093/annonc/mds226 Tanvetyanon, 2008, Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis, J Clin Oncol, 26, 1142, 10.1200/JCO.2007.14.2091 Raz, 2011, Outcomes of patients with isolated adrenal metastasis from nonsmall cell lung carcinoma, Ann Thorac Surg, 92, 178, 10.1016/j.athoracsur.2011.05.116 Howell, 2013, Outcome and prognostic factors after adrenalectomy for patients with distant adrenal metastasis, Ann Surg Oncol, 20, 3491, 10.1245/s10434-013-3050-2 Griffioen, 2013, Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors, Lung Cancer, 82, 95, 10.1016/j.lungcan.2013.07.023 Wroński, 1995, Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991, J Neurosurg, 83, 605, 10.3171/jns.1995.83.4.0605 Azzoli, 2011, 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer, J Clin Oncol, 29, 3825, 10.1200/JCO.2010.34.2774 Mussi, 1996, Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors, J Thorac Cardiovasc Surg, 112, 146, 10.1016/S0022-5223(96)70190-3 Bonnette, 2001, Surgical management of non-small cell lung cancer with synchronous brain metastases, Chest, 119, 1469, 10.1378/chest.119.5.1469 Simonová, 2000, Solitary brain metastases treated with the Leksell gamma knife: prognostic factors for patients, Radiother Oncol, 57, 207, 10.1016/S0167-8140(00)00267-X Flannery, 2003, Gamma knife stereotactic radiosurgery for synchronous versus metachronous solitary brain metastases from non-small cell lung cancer, Lung Cancer, 42, 327, 10.1016/S0169-5002(03)00357-X Hu, 2006, Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis, Cancer, 106, 1998, 10.1002/cncr.21818 Andrews, 2004, Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial, Lancet, 363, 1665, 10.1016/S0140-6736(04)16250-8 Mehta, 2005, The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases, Int J Radiat Oncol Biol Phys, 63, 37, 10.1016/j.ijrobp.2005.05.023 Kocher, 2011, Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study, J Clin Oncol, 29, 134, 10.1200/JCO.2010.30.1655 Patil, 2010, Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases, Cochrane Database Syst Rev, 10.1002/14651858.CD006121.pub2 Rami-Porta, 2007, The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer, J Thorac Oncol, 2, 593, 10.1097/JTO.0b013e31807a2f81 Martini, 1975, Multiple primary lung cancers, J Thorac Cardiovasc Surg, 70, 606, 10.1016/S0022-5223(19)40289-4 Le Pimpec Barthes, 2012, Place de la chirurgie dans le cancer bronchique non à petites cellules métastatique, Rev Mal Respir, 29, 376, 10.1016/j.rmr.2011.07.010 Riquet, 2008, Multiple lung cancers prognosis: what about histology?, Ann Thorac Surg, 86, 921, 10.1016/j.athoracsur.2008.05.041 Rivière, 2011, Cancer bronchique bifocal: une même histologie?, Rev Pneumol Clin, 67, 113, 10.1016/j.pneumo.2009.12.015 Salah, 2012, Metastatectomy for extracranial extra-adrenal non-small cell lung cancer solitary metastases: systematic review and analysis of reported cases, Lung Cancer, 75, 9, 10.1016/j.lungcan.2011.07.014 Lopez Guerra, 2012, Prognostic Impact of Radiation Therapy to the Primary Tumor in Patients With Non-small Cell Lung Cancer and Oligometastasis at Diagnosis, Int J Radiat Oncol Biol Phys, 84, e61, 10.1016/j.ijrobp.2012.02.054 Mehta, 2004, Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment, Int J Oncol, 25, 1677 Lussier, 2011, MicroRNA expression characterizes oligometastasis(es), PLoS One, 6, e28650, 10.1371/journal.pone.0028650 Kalluri, 2009, The basics of epithelial-mesenchymal transition, J Clin Invest, 119, 1420, 10.1172/JCI39104 Lussier, 2012, Oligo and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs, PLoS One, 7, e50141, 10.1371/journal.pone.0050141